Publications

Title

Author

Year

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

Watt, JP; Wolfson, LJ; O'Brien, KL; Henkle, E; Deloria-Knoll, M; McCall, N; Lee, E; Levine, OS; Hajjeh, R; MULHOLLAND, K; Cherian, T; Hib and Pneumococcal Global Burden of Disease Stud,;

2009

Lancet, (2009).374 9693 10.1016/S0140-6736(09)61203-4.

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

O'Brien, KL; Wolfson, LJ; Watt, JP; Henkle, E; Deloria-Knoll, M; McCall, N; Lee, E; MULHOLLAND, K; Levine, OS; Cherian, T; Hib and Pneumococcal Global Burden of Disease Stud,;

2009

Lancet, (2009).374 9693 10.1016/S0140-6736(09)61204-6.

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Walker, LM; Phogat, SK; Chan-Hui, P-Y; Wagner, D; Phung, P; Goss, JL; Wrin, T; Simek, MD; Fling, S; Mitcham, JL; Lehrman, JK; Priddy, FH; Olsen, OA; Frey, SM; Hammond, PW; Protocol G Principal Investigators,; Kaminsky, S; Zamb, T; Moyle, M; Koff, WC; Poignard, P; Burton, DR;

2009

Science (New York, NY), (2009).326 5950 10.1126/science.1178746.

Do we still need a malaria vaccine?.

GREENWOOD, B; TARGETT, G;

2009

Parasite immunology, (2009).31 9 10.1111/j.1365-3024.2009.01140.x.

Pandemic H1N1 infection in pregnant women in the USA.

MANGTANI, P; Mak, TK; Pfeifer, D;

2009

Lancet, (2009).374 9688 10.1016/S0140-6736(09)61431-8.

Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso.

Nebie, I; Diarra, A; Ouedraogo, A; Tiono, AB; Konate, AT; Gansane, A; Soulama, I; COUSENS, S; Leroy, O; Sirima, SB;

2009

Parasite immunology, (2009).31 8 10.1111/j.1365-3024.2009.01130.x.

Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?.

SUTHERLAND, CJ;

2009

Molecular and biochemical parasitology, (2009).166 2 10.1016/j.molbiopara.2009.03.007.

Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.

Woodhall, SC; JIT, M; Cai, C; Ramsey, T; Zia, S; Crouch, S; Birks, Y; NEWTON, R; EDMUNDS, WJ; Lacey, CJ N;

2009

Sexually transmitted diseases, (2009).36 8 10.1097/OLQ.0b013e3181a74c2c.

Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection.

Mueller, I; Moorthy, VS; Brown, GV; SMITH, PG; Alonso, P; Genton, B; WHO Malaria Vaccine Advisory Committee (MALVAC),;

2009

Vaccine, (2009).27 41 10.1016/j.vaccine.2009.07.018.

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.

Lusingu, JP A; Gesase, S; Msham, S; Francis, F; Lemnge, M; Seth, M; Sembuche, S; Rutta, A; Minja, D; Segeja, MD; Bosomprah, S; COUSENS, S; Noor, R; Chilengi, R; Druilhe, P;

2009

Malaria journal, (2009).8 1 10.1186/1475-2875-8-163.